Ignite Creation Date:
2025-12-25 @ 2:00 AM
Ignite Modification Date:
2026-03-03 @ 4:14 AM
Study NCT ID:
NCT02068794
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-11-18
First Post:
2014-02-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
MV-NIS Infected Mesenchymal Stem Cells in Treating Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Sponsor:
Mayo Clinic
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Fallopian Tube Clear Cell Adenocarcinoma | View |
| None | Fallopian Tube Endometrioid Adenocarcinoma | View |
| None | Fallopian Tube Mucinous Adenocarcinoma | View |
| None | Fallopian Tube Serous Adenocarcinoma | View |
| None | Fallopian Tube Transitional Cell Carcinoma | View |
| None | Fallopian Tube Undifferentiated Carcinoma | View |
| None | Malignant Ovarian Brenner Tumor | View |
| None | Ovarian Clear Cell Adenocarcinoma | View |
| None | Ovarian Endometrioid Adenocarcinoma | View |
| None | Ovarian Mucinous Adenocarcinoma | View |
| None | Ovarian Seromucinous Carcinoma | View |
| None | Ovarian Serous Adenocarcinoma | View |
| None | Ovarian Transitional Cell Carcinoma | View |
| None | Ovarian Undifferentiated Carcinoma | View |
| None | Primary Peritoneal Serous Adenocarcinoma | View |
| None | Recurrent Fallopian Tube Carcinoma | View |
| None | Recurrent Ovarian Carcinoma | View |
| None | Recurrent Primary Peritoneal Carcinoma | View |
Keywords: